Serum β-Catenin Levels Associated with the Ratio of RANKL/OPG in Patients with Postmenopausal Osteoporosis

Table 3

Result for multiple regressions in PMOP group and in control group.

	PMOP group					Control group
	𝐵	SE	𝛽	𝑡	Sig.	𝐵	SE	𝛽	𝑡	Sig.
Age	−0.059	0.171	−0.014	−0.348	0.728	−0.097	0.126	−0.063	−0.775	0.439
BMI	−0.312	0.364	−0.035	−0.859	0.391	0.331	0.269	0.098	1.229	0.221
BMD	−18.870	9.533	−0.093	−1.979	0.048	−3.708	5.920	−0.050	−0.626	0.532
Estradiol	−0.011	0.040	−0.011	−0.279	0.780	−0.030	0.029	−0.087	−1.014	0.312
N-MID-OT	0.173	0.103	0.070	1.682	0.093	0.010	0.083	0.011	0.126	0.900
25(OH)D	0.024	0.122	0.008	0.197	0.844	−0.004	0.099	−0.003	−0.039	0.969
CTX	−3.369	7.680	−0.020	−0.439	0.661	−7.431	8.829	−0.088	−0.842	0.401
PINP	−0.169	0.069	−0.103	−2.451	0.015	−0.025	0.047	−0.046	−0.526	0.600
Sclerostin	−0.684	0.089	−0.343	−7.721	<0.001	0.106	0.067	0.130	1.599	0.112
OPG	0.047	0.007	0.291	7.174	<0.001	0.003	0.008	0.036	0.349	0.727
RANKL	0.011	0.006	0.073	1.836	0.067	0.014	0.008	0.136	1.676	0.096